Pfizer Inc. (ETR:PFE)

Germany flag Germany · Delayed Price · Currency is EUR
21.81
-0.04 (-0.18%)
Jul 14, 2025, 5:38 PM CET
-17.87%
Market Cap 123.36B
Revenue (ttm) 57.67B
Net Income (ttm) 7.28B
Shares Out n/a
EPS (ttm) 1.28
PE Ratio 16.95
Forward PE 9.02
Dividend 1.57 (7.19%)
Ex-Dividend Date May 9, 2025
Volume 20,747
Average Volume 42,928
Open 21.92
Previous Close 21.85
Day's Range 21.74 - 21.95
52-Week Range 18.57 - 29.50
Beta 0.49
RSI 59.68
Earnings Date Aug 5, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Deutsche Börse Xetra
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys

High-yield S&P 500 stocks can be risky, but 14 "safer" S&P 500 dividend dogs have strong free cash flow to support payouts and are attractive buys. Analyst forecasts suggest top ten S&P 500 dividend d...

2 days ago - Seeking Alpha

Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony

The Delaware Supreme Court has overturned a lower court’s decision that allowed expert testimony supporting plaintiffs’ claims in a high-profile case alleging that Zantac, or its generic ranitidine, c...

3 days ago - Benzinga

Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (OTC: ALPMF) (OTC: ALPMY) on Thursday released topline results from the overall survival (OS) analysis from the Phase 3 EMBARK study evaluating Xtan...

4 days ago - Benzinga

3 To Watch Of 23 'Safer' July Dividends From 46 Fortune World's Most Admired Companies

I analyze the 50 Fortune World's Most Admired Companies, focusing on dividend-paying stocks and their yield-based investment potential. Three companies—Pfizer, BMW, and Singapore Airlines—currently me...

4 days ago - Seeking Alpha

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a long-run...

4 days ago - Reuters

XTANDI Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the overall survival (OS) analysis from the Pha...

4 days ago - Wallstreet:Online

XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence

NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive topline results from the overall ...

4 days ago - Business Wire

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical and public health organizations, including the Ameri...

6 days ago - Benzinga

Healthy Returns: Medicaid cuts in Trump's megabill may affect some drugmakers more than others

Trump's "big beautiful" bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of digital health funding this year.

6 days ago - CNBC

My Top 10 High-Yield Dividend Stocks For July 2025: One Yields 12%-Plus

I present my top 10 high-yield dividend stocks for July 2025, screened for strong yields, large market caps, and attractive valuations. The list includes Chevron, Pfizer, PepsiCo, Ares Capital, BB Seg...

6 days ago - Seeking Alpha

Forget Get Rich Quick: The Real Dividend Strategy That Built My Income Machine

Most people either don't invest, or chase get-rich-quick schemes, which usually leads to disappointment or losses. Setting realistic, achievable financial goals based on savings rate and projected wea...

7 days ago - Seeking Alpha

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (July 2025)

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter...

9 days ago - Seeking Alpha

Recent Report Shows That Sen. Ron L Wyden Sold Up to $15K Worth of Pfizer Stock

On July 2, 2025, it was reported that Senator Ron L Wyden executed a sale of Pfizer (NYSE: PFE) stock, valued between $1,001 and $15,000. The transaction, recorded in the July filing, was made on Jun...

11 days ago - Benzinga

Pfizer: Options Activity Speaks Bullish

11 days ago - Seeking Alpha

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

11 days ago - Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

11 days ago - Benzinga

Is Pfizer Stock a Yield Trap?

11 days ago - The Motley Fool

If AstraZeneca goes to the US it will be a major blow for London and Labour

Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZe...

12 days ago - The Guardian

Cannabis Lighting Market Report 2025-2030 | Share Analysis, Industry Trends & Statistics, Growth Forecasts - Pfizer Ventures into Cannabis with $6.7 Billion Deal, Boosting Industry Growth

The Cannabis Lighting Market is set to grow at a CAGR of 7.6% during the forecast period, driven by rising medical cannabis use and cultivation. Key players like Pfizer are entering the market. LED li...

13 days ago - GlobeNewsWire

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the company's COVID-19 vaccine...

14 days ago - Reuters

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

CAMBRIDGE, Mass. , June 29, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaki...

14 days ago - PRNewsWire